跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CIPGABLINpregabalin 225 mg capsule blister - TGA Drug Approval Details
Approvals
/
TGA
/
CIPGABLINpregabalin 225 mg capsule blister
Approved
STANDARD
CIPGABLINpregabalin 225 mg capsule blister
Cipla Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
549f595df731be51
Company
Cipla Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
549f595df731be51
Product Name
CIPGABLINpregabalin 225 mg capsule blister
Artg Id
317734
Artg Name
CIPGABLIN pregabalin 225 mg capsule blister
Sponsor
Cipla Australia Pty Ltd
Company Detail Path
/organization/cipla-australia-pty-ltd
Artg Date
2020-04-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
549f595df731be51
Type
Standard
Back to TGA Approvals
